Clorox Stock Edges Higher on Q4 Earnings Beat, Mixed Outlook

Shares of The Clorox Company (NYSE: CLX) gained in pre-market trading after the company reported fiscal fourth-quarter financial results that narrowly beat Wall Street expectations. The modest stock move reflects a mixed outlook for the upcoming fiscal year, which tempered investor enthusiasm.

Q4 Results Surpass Forecasts

Clorox announced its fourth-quarter results after Monday's market close, revealing a slight but positive performance. The company's acquisition of GOJO Industries in April 2026 was a significant contributor, accounting for approximately 10 percentage points of sales growth in the quarter.

• Adjusted Earnings Per Share (EPS): $1.66, just ahead of the consensus estimate of $1.65.
• Revenue: $1.95 billion, surpassing analyst forecasts of $1.91 billion.

In a move signaling confidence in its financial position, Clorox's board of directors also approved a quarterly dividend increase to $1.25 per share from $1.24. The dividend is payable on August 28, 2026.

Mixed Outlook and Headwinds

Ad

Despite the quarterly beat, Clorox's guidance for fiscal year 2027 presented a more complex picture for investors. The company projects net sales growth of 13% to 14%, which is above the analyst consensus of approximately 12.8%. However, its adjusted EPS forecast of $5.70 to $6.00 came in slightly below the Wall Street consensus of around $5.97 at the midpoint.

The company also faces persistent challenges that are weighing on profitability. Organic sales saw a sharp decline in the fourth quarter as Clorox lapped a prior-year period that included an inventory build-up related to its ERP system rollout. Furthermore, gross margins compressed due to elevated commodity inflation, a key headwind noted in the report.

Market Context

The stock's modest pre-market gain of 0.2% reflects the balance of positive quarterly results against a cautious forward-looking view. The combination of margin pressure, soft organic sales trends, and an uninspiring EPS outlook has kept the gains in check. The share price remains well below its 52-week high, indicating ongoing investor concerns about the company's path to restoring profitability amid a recent leadership transition.